Chemical Structure (Actoplus 01)
Actoplus Met Tablet, Film Coated
Product Images NDC 64764-158
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Actoplus Met (NDC 64764-158). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Actoplus 02)
Actoplus Met 15mg-500mg 60 Count Bottle Label (Actoplus 03)
This is a description of a medication called Actoplus Met. The medication comes in a container with 60 tablets that weigh 8 ounces. The container should be stored in a dry and cool place. Each tablet contains pioglitazone hydrochloride equivalent to 15 mg of pioglitazone and metformin HCI 500 mg. The medication is distributed by Takeda Pharmaceuticals America in Lexington, WA. A medication guide is included in the package. More information can be found on the website www.actoplusmet.com. The medication requires a prescription.*
Actoplus Met 15mg-850mg 60 Count Bottle Label (Actoplus 04)
This appears to be the label of Actoplus Met, a medication used to treat type 2 diabetes. It contains 15mg of pioglitazone and 850mg of metformin HCl per tablet. The container should be stored between 16 and 30 degrees Celsius and kept away from children. The medication should be dispensed with a medication guide, which is available online or in the package insert. The manufacturer is Takeda Pharmaceuticals, based in America, and the product is made in Japan.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
